Biopharma execs give Scott Gottlieb’s nomination for FDA commish (almost) a standing O in Endpoints poll
A big majority of biopharma executives overall are clearly enthusiastic about President Trump’s decision to nominate Scott Gottlieb as the next FDA commissioner. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
